IMNN
Imunon, Inc. Common StockstockNASDAQ
At CloseNov 18, 2026 3:59:27 PM EST
0.57USD-6.223%(-0.04)75,472
After-hoursNov 18, 2026 4:00:30 PM EST
0.5858USD+2.038%(+0.0117)
Loading…
Loading…
3.80M
Healthcare
Biotechnology
HQ
Lawrenceville, NJ, USA
Previous Close
$0.61
Beta
0.53
52-Week High
$4.35 2025-12-10
52-Week Low
$0.50 2026-11-12
SMA 50
$1.10
SMA 200
$2.06
Avg. Vol 10D
330,677
Avg. Vol 30D
187,438
Avg. Vol 90D
171,179
Relative Vol
0.40
6.49M
5.15M
79.32%
215,645
4.48%
1.49
39%/61%
44.91%
28.13%
9.9000%
11,909
6,546
12,794
Aug 7, 2025 · 1-for-1
-15.0M
-13.9M
-448.57
Nov 12, 2026
Imunon (IMNN) Q3 2026 Earnings Call Transcript ·
The Motley Fool+1 source
Q3 2026 Imunon Inc Earnings Call Transcript ·
GuruFocus
Imunon, Inc. (IMNN) Q3 2026 Earnings Call Transcript ·
Seeking Alpha
IMNN Profile
celsion is a biopharmaceutical company dedicated to the research and development of innovative, targeted therapies that address unmet medical needs in oncology. with the recent acquisition of egen, inc., celsion has become a fully integrated company with an extensive, complementary, multi-phase clinical pipeline; platform technologies for the discovery of novel, nucleic acid-based immunotherapies and other anti-cancer dna/rna therapies; and expertise from bench to bedside.
IMNN Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.64 | 2026-11-12 | -8.07% | 0.896 |
| 1M | 0.99 | 2026-10-19 | -40.57% | -0.310 |
| 3M | 1.58 | 2026-08-19 | -62.95% | 0.223 |
| 6M | 2.23 | 2026-05-19 | -73.75% | 0.329 |
| 1Y | 3.78 | 2025-11-19 | -84.51% | 0.528 |
| 2Y | 9.01 | 2024-11-19 | -93.50% | — |
| 5Y | 23.87 | 2022-09-21 | -97.55% | 0.589 |
IMNN Stock Summary
Imunon, Inc. Common Stock (NASDAQ:IMNN) stock price today is $0.59, and today's volume is 75,472. IMNN is down 4.378% today. The 30 day average volume is 187,438. IMNN market cap is $3.80M with 6.49M shares outstanding.